🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of surovatam...
Status
Recruiting
Location
Research Site
Start Date
2025-01-30
Trial ID
NCT06564038
This study is designed to evaluate the efficacy of acalabrutinib compared w...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-02-02
Trial ID
NCT02970318
Treatments Being Tested
Study to determine the preliminary safety, tolerability, and pharmacokineti...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2021-03-02
Trial ID
NCT04419389
To characterize the safety and efficacy of acalabrutinib (ACP-196) monother...
Status
Completed
Location
Arizona Gynecology Oncology
Start Date
2015-11
Trial ID
NCT02537444
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-10-19
Trial ID
NCT04560322
Treatments Being Tested
People who have chronic lymphocytic leukemia (CLL) or small lymphocytic lym...
Status
Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2025-10-01
Trial ID
NCT06520098
Treatments Being Tested
Platelet transfusion refractoriness (PTR) is a common complication in patie...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07635511
This is an open-label, multicenter, phase 2, non-randomized study aiming to...
Status
Recruiting
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2025-12-01
Trial ID
NCT06958705
This Primary objective is evaluating the efficacy of obinutuzumab in combin...
Status
Active Not Recruiting
Location
Research Site
Start Date
2015-06-26
Trial ID
NCT02475681
Treatments Being Tested
The STELLAR trial will assess the effect of acalabrutinib taken in combinat...
Status
Active Not Recruiting
Location
Belfast City Hospital
Start Date
2019-07-23
Trial ID
NCT03899337
Treatments Being Tested